文献速递关节外科创伤骨科

初次反式全肩关节置换术中肩胛盂骨缺损的处理:系统综述与Meta分析

Management of glenoid bone loss in primary reverse shoulder arthroplasty : a systematic review and meta-analysis.
PubMed 文献 · Bone Joint J · 2022-01-01

该系统综述与Meta分析比较了骨移植与增强肩胛盂假体在初次反式全肩关节置换术中处理肩胛盂骨缺损的效果,纳入13项研究共919肩。两种技术均改善患者报告结局和活动度,增强假体在ASES评分改善上更优,骨移植组并发症率和翻修率更高。

要点

  • 骨移植与增强肩胛盂基板两种技术均能改善初次反式全肩关节置换患者的活动度和功能结局。
  • 增强假体在ASES评分改善上优于骨移植。
  • 骨移植组并发症率8.9%高于增强假体组3.5%(p < 0.001),翻修率2.4%高于0.6%(p = 0.022)。

核心结论

  • 该系统综述与Meta分析提供强证据表明,骨移植和增强肩胛盂基板技术处理肩胛盂骨缺损在初次反式全肩关节置换中均能带来优良的活动度和功能结局。
  • 使用增强基板可能带来更少的并发症和翻修。

研究设计与样本

  • 系统综述与Meta分析,按照PRISMA声明评估研究水平数据。
  • 检索Medline(Ovid)、Embase(Ovid)和PubMed从建库至2022年1月。
  • 共纳入13项研究(919肩),患者初次评估平均年龄72.2岁(42至87),平均随访40.7个月(24至120)。
  • 9项研究共292肩评估骨移植的使用,5项研究共627肩评估增强肩胛盂基板的使用,1项研究在两组中均被分析。

主要发现

  • 两种技术均显示患者报告结局测量和活动度评估的改善,增强假体在美国肩肘外科医师评分改善上优于骨移植。
  • 骨移植组并发症率8.9% vs 增强假体组3.5%(p < 0.001)。
  • 骨移植组翻修率2.4% vs 增强假体组0.6%(p = 0.022)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Rates of reverse total shoulder arthroplasty (rTSA) continue to grow. Glenoid bone loss and deformity remains a technical challenge to the surgeon and may reduce improvements in patients' outcomes. However, there is no consensus as to the optimal surgical technique to best reconstruct these patients' anatomy. This review aims to compare the outcomes of glenoid bone grafting versus augmented glenoid prostheses in the management of glenoid bone loss in primary reverse total shoulder arthroplasty. METHODS: This systematic review and meta-analysis evaluated study-level data in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. We performed searches of Medline (Ovid), Embase (Ovid), and PubMed from their dates of inception to January 2022. From included studies, we analyzed data for preoperative and postoperative range of motion (ROM), patient-reported functional outcomes, and complication rates. RESULTS: A total of 13 studies (919 shoulders) were included in the analysis. The mean age of patients at initial evaluation was 72.2 years (42 to 87), with a mean follow-up time of 40.7 months (24 to 120). Nine studies with 292 rTSAs evaluated the use of bone graft and five studies with 627 rTSAs evaluated the use of augmented glenoid baseplates. One study was analyzed in both groups. Both techniques demonstrated improvement in patient-reported outcome measures and ROM assessment, with augmented prostheses outperforming bone grafting on improvements in the American Shoulder and Elbow Surgeons Score. There was a higher complication rate (8.9% vs 3.5%; p < 0.001) and revision rate among the bone grafting group compared with the patients who were treated with augmented prostheses (2.4% vs 0.6%; p = 0.022). CONCLUSION: This review provides strong evidence that both bone graft and augmented glenoid baseplate techniques to address glenoid bone loss give excellent ROM and functional outcomes in primary rTSA. The use of augmented base plates may confer fewer complications and revisions.Cite this article: Bone Joint J 2022;104-B(12):1334-1342.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Wilcox B, Campbell RJ, Low AK, et al. Management of glenoid bone loss in primary reverse shoulder arthroplasty : a systematic review and meta-analysis. Bone Joint J. 2022. PMID: 36453050. doi:10.1302/0301-620X.104B12.BJJ-2022-0819.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。